Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Memantine Hydrochloride. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103553932A details a safer, scalable route for Memantine HCl using controlled exotherms and green solvents, offering cost-effective API intermediate manufacturing.
Patent CN103288650A details a high-yield Memantine synthesis using phosphoric acid catalysis, offering significant cost reduction in pharmaceutical manufacturing and scalable supply chain solutions.
Novel homogeneous phase method for memantine hydrochloride. High yield 69.5%, purity 99.98%. Cost-effective scale-up for pharmaceutical supply chains.
Patent CN103553932B offers safer Ritter reaction route. Reduces toxicity and improves scalability for API manufacturing. Reliable supply chain partner for global pharmaceutical intermediates.